Nourah's Tissue Biobank, Saudi Arabia

Certification Status: Approved

Registration Status: Completed

Objective: Nourah’s Tissue Biobank will serve as a library for researchers as it will involve the collection and the storage of biological samples, mainly tissues, and health information. Nourah’s Tissue Biobank aims to create a rich source of data to advance molecular and clinical research and support scientific knowledge which align with the vision of Saudi Arabia 2030. It will enable researchers within the Kingdome to gain access to a collection of stored samples and health information to be used for medical research purposes. Nourah’s Tissue Biobank ultimate goal is to support the scientific progress and improve our understanding and knowledge on disease diagnosis, prevention, and treatment which will provide a significant contribution to Saudi community. Our experienced logistics team will ensure that we provide a high-quality service and we will work with national and international institutes, proprietary network of principal investigators, to source and collect samples from multi-center hospitals and other biobanks. All the samples collected in the field are carefully transported to our facility using the best techniques for preservation. We will make sure bio-specimens will be accurately and quickly registered upon arrival. They will be then added to our online database with accurate, up-to-date health information. Nourah’s Tissue Biobank will be powered by our proprietary LMS system and connects all facets of our business into one platform. It facilitates smooth and efficient processes between Nourah’s Tissue Biobank, hospitals and researchers.

Registered Biobank Name	Nourah's Tissue Biobank
Biobank Leader	Dr. Alaa A. Al-Masud
Country	Saudi Arabia
Email for biobank inquiries	aaalmasud@pnu.edu.sa
Principal Investigator	Dr. Alaa A. Al-Masud
Website	https://biobank.kaauh.edu.sa/
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).